Month: May 2020

Lánasjóður sveitarfélaga hefur ákveðið að efna til útboðs á skuldabréfum í flokkum LSS150434 og LSS151155 miðvikudaginn 13. maí 2020. Lánasjóðurinn stefnir að því að taka tilboðum að fjárhæð 500 m.kr. að markaðsvirði í LSS151155 og 2.000 m.kr. að markaðsvirði í LSS150434. Lánasjóðurinn áskilur sér rétt til að hækka og lækka útboðsfjárhæð útboðsins, taka hvaða tilboði sem er eða hafna þeim öllum. Lánasjóðurinn hefur boðið aðalmiðlurum sjóðsins Arion banka, Íslandsbanka, Kviku banka og Landsbankanum að taka þátt í útboðinu.Óskað er eftir tilboðum í samræmi við eftirfarandi lýsingu:ViðhengiLánasjóður sveitarfélaga – Útboðsskilmálar LSS34 & LSS55

Philadelphia, PA, May 11, 2020 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC:VSBGF) (“VSBLTY”), a leading provider of security and retail marketing technology, announced today that they have joined forces with a global cyber security product and building services company to provide advanced camera technology that enhances security and enables COVID-19 temperature screenings before people enter office buildings.The announcement was made by VSBLTY Co-founder & CEO Jay Hutton. “In order to get the economy running again it is critical to assure workplace safety for both employers and employees. We now will have the technology that provides for wellness analysis, capacity management and density metrics to allow for real time building safety. This technology will enable buildings to provide safe...

SALT LAKE CITY, May 11, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) approved the myChoice CDx® test for use as a companion diagnostic by healthcare professionals to identify advanced ovarian cancer patients with positive homologous recombination deficiency (HRD) status, who are eligible or may become eligible, for first-line maintenance treatment with Lynparza (olaparib) in combination with bevacizumab. Lynparza (olaparib) is a novel PARP inhibitor jointly developed and commercialized by AstraZeneca (LSE/STO/NYSE: AZN) and Merck, known as MSD outside of the U.S. and Canada. “We congratulate AstraZeneca and Merck on obtaining another FDA approval of Lynparza for women with advanced ovarian cancer,”...

Topline results for lenabasum Phase 3 RESOLVE-1 study in systemic sclerosis remain on schedule for summer of 2020, followed by Phase 2b study data in cystic fibrosisPhase 1 trial of CRB-4001 remains on track to initiate in third quarter of 2020Recent appointment of Dr. Pete Salzmann to Board of DirectorsImplemented COVID-19 mitigation and monitoring plan to ensure patient safety, data integrity and completion of key clinical studiesCompany to host conference call and webcast today, May 11, 2020 at 8:30 a.m. ETNorwood, MA, May 11, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today reported financial results for the first quarter of 2020. The Company also...

OKLAHOMA CITY, May 11, 2020 (GLOBE NEWSWIRE) — Mammoth Energy Services, Inc. (“Mammoth” or the “Company”) (NASDAQ: TUSK) today reported financial and operational results for the first quarter ended March 31, 2020.Financial Highlights for the First Quarter 2020:Total revenue was $97.4 million for the three months ended March 31, 2020, up from $67.6 million for the three months ended December 31, 2019 and down from $262.1 million for the three months ended March 31, 2019.Net loss for the three months ended March 31, 2020 was $84.0 million, or $1.85 per fully diluted share, as compared to net loss of $60.8 million, or $1.35 per fully diluted share, for the three months ended December 31, 2019 and net income of $28.3 million, or $0.63 per fully diluted share, for the three months ended March 31, 2019.Adjusted net loss (as defined and...

HOUSTON, May 11, 2020 (GLOBE NEWSWIRE) — SEACOR Marine Holdings Inc. (NYSE:SMHI) (the “Company” or “SEACOR Marine”), a leading provider of marine and support transportation services to offshore oil and natural gas and wind farm facilities worldwide, today announced results for its first quarter ended March 31, 2020.Notable first quarter items include:Average dayrates, excluding those for the crew transfer vessel fleet, increased to $11,157 in the first quarter of 2020 from $11,071 in the fourth quarter of 2019. The improved average dayrates reflect the change in the Company’s fleet mix over the period. SEACOR Marine closed its acquisition of the remaining minority interests in Falcon Global Holdings LLC, increasing its ownership stake to 100%. Obtaining full ownership of the liftboat fleet will allow SEACOR Marine to manage the...